Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells

Background. Chemical biology approaches using small molecule inhibitors targeting specific signaling pathways are useful tools to dissect the molecular mechanisms governing stem cell differentiation and for their possible use in therapeutic interventions. Methods. Stem cell signaling small molecule...

Full description

Saved in:
Bibliographic Details
Main Authors: Nihal AlMuraikhi, Dalia Ali, Radhakrishnan Vishnubalaji, Muthurangan Manikandan, Muhammad Atteya, Abdulaziz Siyal, Musaad Alfayez, Abdullah Aldahmash, Moustapha Kassem, Nehad M. Alajez
Format: Article
Language:English
Published: Wiley 2019-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2019/3041262
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850120949987278848
author Nihal AlMuraikhi
Dalia Ali
Radhakrishnan Vishnubalaji
Muthurangan Manikandan
Muhammad Atteya
Abdulaziz Siyal
Musaad Alfayez
Abdullah Aldahmash
Moustapha Kassem
Nehad M. Alajez
author_facet Nihal AlMuraikhi
Dalia Ali
Radhakrishnan Vishnubalaji
Muthurangan Manikandan
Muhammad Atteya
Abdulaziz Siyal
Musaad Alfayez
Abdullah Aldahmash
Moustapha Kassem
Nehad M. Alajez
author_sort Nihal AlMuraikhi
collection DOAJ
description Background. Chemical biology approaches using small molecule inhibitors targeting specific signaling pathways are useful tools to dissect the molecular mechanisms governing stem cell differentiation and for their possible use in therapeutic interventions. Methods. Stem cell signaling small molecule library functional screen was performed employing human bone marrow skeletal (mesenchymal) stem cells (hBMSCs). Alkaline phosphatase (ALP) activity and formation of mineralized matrix visualized by Alizarin red staining were employed as markers for osteoblastic differentiation. Global gene expression profiling was conducted using the Agilent microarray platform, and data normalization and bioinformatics were performed using GeneSpring software. Pathway analyses were conducted using the Ingenuity Pathway Analysis (IPA) tool. In vivo ectopic bone formation was performed using hBMSC mixed with hydroxyapatite–tricalcium phosphate granules that were implanted subcutaneously in 8-week-old female nude mice. Hematoxylin and eosin staining and Sirius red staining were performed to identify bone formation in vivo. Results. Among the tested molecules, LY411575, a potent γ-secretase and Notch signaling inhibitor, exhibited significant inhibitory effects on osteoblastic differentiation of hBMSCs manifested by reduced ALP activity, mineralized matrix formation, and decreased osteoblast-specific gene expression as well as in vivo ectopic bone formation. Global gene expression profiling of LY411575-treated cells revealed changes in multiple signaling pathways, including focal adhesion, insulin, TGFβ, IL6, and Notch signaling, and decreased the expression of genes associated with functional categories of tissue development. Among the affected signaling networks were TGFβ1, SPP1, and ERK regulatory networks. Conclusions. We identified γ-secretase inhibitor (LY411575) as a potent regulator of osteoblastic differentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with ectopic bone formation.
format Article
id doaj-art-62dfd20a09014b97bcfeed25b81a45d6
institution OA Journals
issn 1687-966X
1687-9678
language English
publishDate 2019-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-62dfd20a09014b97bcfeed25b81a45d62025-08-20T02:35:14ZengWileyStem Cells International1687-966X1687-96782019-01-01201910.1155/2019/30412623041262Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem CellsNihal AlMuraikhi0Dalia Ali1Radhakrishnan Vishnubalaji2Muthurangan Manikandan3Muhammad Atteya4Abdulaziz Siyal5Musaad Alfayez6Abdullah Aldahmash7Moustapha Kassem8Nehad M. Alajez9Stem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaCancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, QatarStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaStem Cell Unit, Department of Anatomy, College of Medicine, King Saud University, Riyadh 11461, Saudi ArabiaCancer Research Center, Qatar Biomedical Research Institute (QBRI), Hamad Bin Khalifa University (HBKU), Qatar Foundation (QF), PO Box 34110, Doha, QatarBackground. Chemical biology approaches using small molecule inhibitors targeting specific signaling pathways are useful tools to dissect the molecular mechanisms governing stem cell differentiation and for their possible use in therapeutic interventions. Methods. Stem cell signaling small molecule library functional screen was performed employing human bone marrow skeletal (mesenchymal) stem cells (hBMSCs). Alkaline phosphatase (ALP) activity and formation of mineralized matrix visualized by Alizarin red staining were employed as markers for osteoblastic differentiation. Global gene expression profiling was conducted using the Agilent microarray platform, and data normalization and bioinformatics were performed using GeneSpring software. Pathway analyses were conducted using the Ingenuity Pathway Analysis (IPA) tool. In vivo ectopic bone formation was performed using hBMSC mixed with hydroxyapatite–tricalcium phosphate granules that were implanted subcutaneously in 8-week-old female nude mice. Hematoxylin and eosin staining and Sirius red staining were performed to identify bone formation in vivo. Results. Among the tested molecules, LY411575, a potent γ-secretase and Notch signaling inhibitor, exhibited significant inhibitory effects on osteoblastic differentiation of hBMSCs manifested by reduced ALP activity, mineralized matrix formation, and decreased osteoblast-specific gene expression as well as in vivo ectopic bone formation. Global gene expression profiling of LY411575-treated cells revealed changes in multiple signaling pathways, including focal adhesion, insulin, TGFβ, IL6, and Notch signaling, and decreased the expression of genes associated with functional categories of tissue development. Among the affected signaling networks were TGFβ1, SPP1, and ERK regulatory networks. Conclusions. We identified γ-secretase inhibitor (LY411575) as a potent regulator of osteoblastic differentiation of hBMSC that may be useful as a therapeutic option for treating conditions associated with ectopic bone formation.http://dx.doi.org/10.1155/2019/3041262
spellingShingle Nihal AlMuraikhi
Dalia Ali
Radhakrishnan Vishnubalaji
Muthurangan Manikandan
Muhammad Atteya
Abdulaziz Siyal
Musaad Alfayez
Abdullah Aldahmash
Moustapha Kassem
Nehad M. Alajez
Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
Stem Cells International
title Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
title_full Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
title_fullStr Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
title_full_unstemmed Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
title_short Notch Signaling Inhibition by LY411575 Attenuates Osteoblast Differentiation and Decreased Ectopic Bone Formation Capacity of Human Skeletal (Mesenchymal) Stem Cells
title_sort notch signaling inhibition by ly411575 attenuates osteoblast differentiation and decreased ectopic bone formation capacity of human skeletal mesenchymal stem cells
url http://dx.doi.org/10.1155/2019/3041262
work_keys_str_mv AT nihalalmuraikhi notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT daliaali notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT radhakrishnanvishnubalaji notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT muthuranganmanikandan notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT muhammadatteya notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT abdulazizsiyal notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT musaadalfayez notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT abdullahaldahmash notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT moustaphakassem notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells
AT nehadmalajez notchsignalinginhibitionbyly411575attenuatesosteoblastdifferentiationanddecreasedectopicboneformationcapacityofhumanskeletalmesenchymalstemcells